Industry News

Novartis, the world's second largest pharmaceutical company, has announced that its antimalarial medicine Coartem 80/480mg received World Health Organisation (WHO) prequalification, making it the first and only high strength (80/480mg) artemisinin-based combination therapy (ACT) antimalarial treatment available for public sector procurement. This new dosage strength has the potential to improve malaria management.

Bosch, a leading global supplier of technology and services, has got the Zinnov Awards for its Eyecare device that was adjudged as an innovation with a potential to solve large scale global problems.

(NewsVoir); Randstad, one of the country’s leading HR service providers, today launched an exclusive ‘Talent Trends Report – HR Game Changers’ at the 12th edition of the NASSCOM HR Summit, held in Chennai. The report offers an overview of the top 15 workplace trends that will shape talent management in 2015 and beyond.

(Business Wire India); Apollo Children’s Hospital has once again showcased its expertise and technical know-how on implementing some of the latest technologies for the benefit of patients. Surgeries performed at the Children’s Hospital using the da Vinci robot provides patients with all the advantages like quicker discharge time, minimal scarring, smaller incisions and less blood loss that conventional laparoscopy offers over open surgeries.

The US Food and Drug Administration (FDA) has approved AstraZeneca's Iressa (gefitinib) tablets, 250mg once daily, for the first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC) whose tumours have epidermal growth factor receptor (EGFR) exon 19 deletions or exon 21 (L858R) substitution mutations, as detected by an FDA-approved test.

Lilly Diabetes  has launched Lilly Glucagon Mobile App, an Android version of its mobile application designed for caregivers and healthcare providers who support people with diabetes.

The US Food and Drug Administration (FDA) has granted Orphan Drug designation to Cleave Biosciences' lead drug candidate, CB-5083 for the treatment of multiple myeloma.

(NewsVoir); 1mg.com, India’s leading m-health platform and ePharmacy network today launched its Diagnostic Test booking service, available through the popular “1mg” mobile app and 1mglabs.com. The m-health startup, which has over 3M downloads and is growing rapidly, has now added a new service to enable users to book wide-ranging diagnosis tests with some of the top quality certified laboratories, ensuring quality service. Presently, top labs like Metropolis, Oncquest, Thyrocare, Molecure, Wellness Pathcare etc are the partners, with plans to add more leading labs in the coming weeks. Currently, the service is available in Delhi NCR, Mumbai, Thane, and Pune. Now, 1mg offers Pharmacy, Diagnostic and also Homeopathy products through its platform as it prepares to be the one point destination for all healthcare content, products and services.

Dr Reddy’s Laboratories has launched the United States Food & Drug Administration (FDA) approved memantine hydrochloride tablets  USP, 5 mg and 10 mg, a therapeutic equivalent generic version of Namenda (memantine HCl) tablets in the US market on July  12, 2015. Dr Reddy’s Memantine hydrochloride tablets USP, 5 mg is available in bottle count size of 60 and the memantine hydrochloride tablets USP, 10 mg are available in bottle count sizes of 60 and 500.

Mylan N.V., a global pharmaceutical company, has launched bexarotene 75mg capsules in US, which is the generic version of Valeant's Targretin capsules. The product is indicated for the treatment of cutaneous manifestations of cutaneous t-cell lymphoma in patients who are refractory to at least one prior systemic therapy.